Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma.

Asian Pac J Allergy Immunol

Department of Respiratory Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, India.

Published: December 2000

Two Hundred patients with bronchial asthma were studied to identify the prevalence of allergic bronchopulmonary aspergillosis (ABPA). The patients selected required intermittent short courses of steroids and their mean duration of illness was 12 years. Absolute eosinophil count was > 500/mm3 in 53% of the cases. Chest X-rays showed small homogenous shadows with patchy infiltrations in 25% and fluctuating pneumonic shadows in 14% of the cases. Raised specific IgG and positive serum precipitin against Aspergillus fumigatus (AF) were present in 24% and 13%, respectively. Cases with radiological and immunological suspicion were further investigated for ABPA. Skin tests for Type-I and Type-III reactivity were positive with AF extract in 87% (n = 47) and 36% (n = 47) of the cases. A thorax CT of 31 patients showed central bronchiectasis in 24 cases, labeling these patients as ABPA-CB (ABPA with central bronchiectasis) and an other 7 as ABPA-S (serological positive). CT was not done in one case who, because of other positive findings, was also labeled as ABPA-S. Thus, these 32 asthmatics were found to have ABPA. Among them, there was raised specific IgG (100%) and raised specifc IgE against AF (100%), positive skin test for Type-I and Type-III reactivity (100% and 53%) against AF. There was elevated total IgE (100%, n = 29), a positive family history of asthma (63%), peripheral eosinophilia (100%) and a history of passage of brownish plugs (31%). Radiological findings suggested soft shadow with infiltration in 31% and fluctuating pneumonic shadows in 69% of cases. CT Thorax (n = 31) showed central bronchiectasis in 78% of theses patients. Based on the present data, the prevalence of ABPA in bronchial asthma patients is 16% (12% with central bronchiectasis and 4% only serologically positive). Therefore, patients should be investigated and diagnosed in an early phase of ABPA (ABPA-S) and should be treated to prevent permanent lung damage.

Download full-text PDF

Source

Publication Analysis

Top Keywords

central bronchiectasis
16
bronchial asthma
12
prevalence allergic
8
allergic bronchopulmonary
8
bronchopulmonary aspergillosis
8
patients
8
patients bronchial
8
asthma patients
8
fluctuating pneumonic
8
pneumonic shadows
8

Similar Publications

Kartagener syndrome (KS) is a rare congenital disorder, characterized by sinusitis, bronchiectasis and situs inversus. Lung transplantation is an effective treatment for end-stage lung failure, but dextrocardia and differences between hilar structures and pulmonary lobes require adjustments to conventional surgical technique. We present a case of a double-lung transplant without extracorporeal oxygenation in a 48-year-old male patient with KS.

View Article and Find Full Text PDF

Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study.

Lancet Respir Med

January 2025

Division of Respiratory Medicine and Gastroenterology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. Electronic address:

Background: Bronchiectasis is a disease with a global impact, but most published data come from high-income countries. We aimed to describe the clinical characteristics of patients with bronchiectasis in China.

Methods: The Chinese Bronchiectasis Registry (BE-China) is a prospective, observational cohort enrolling patients from 111 hospitals in China.

View Article and Find Full Text PDF

State-of-the-art narrative review: Mounier-Kuhn syndrome and tracheobronchomegaly.

Respir Med

December 2024

New York City Health & Hospitals, Woodhull, Brooklyn, NY, 11206, USA; NYU Grossman School of Medicine, Division of Pulmonary Medicine, New York City Health and Hospitals, Woodhull, 760 Broadway, 8th Floor, Brooklyn, NY, 11206, USA. Electronic address:

Mounier-Kuhn syndrome (MKS) or tracheobronchomegaly is an uncommon disease of the central airways. It is characterized by pathological dilatation of the trachea and main bronchi and inevitably leads to recurrent respiratory infections, bronchiectasis, hospitalizations, and results in considerable morbidity and mortality. Despite numerous case reports, there is a shortage of evidence on clinical outcomes and limited data on interventions, thus presenting a significant gap in the literature.

View Article and Find Full Text PDF

Common Variable Immunodeficiency Clinical Manifestations Are Shaped by Presence and Type of Heterozygous NFKB1 Variants.

J Allergy Clin Immunol Pract

December 2024

Pulmonary Center, Section of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Mass. Electronic address:

Background: NFKB1 encodes p105, which is processed to p50 to mediate canonical nuclear factor-κB (NF-κB) signaling. Although NF-κB is a central driver of inflammation and heterozygous NFKB1 variants are considered the most common monogenic etiologies of common variable immunodeficiency (CVID), few studies have explored how NFKB1 variants shape clinical course or inflammation in CVID.

Objective: We leveraged a regional cohort of patients with CVID with and without heterozygous NFKB1 variants to assess how clinical and inflammatory features of CVID are shaped by the presence of these variants.

View Article and Find Full Text PDF

[Evolution of diagnostic criteria for allergic bronchopulmonary aspergillosis].

Zhonghua Jie He He Hu Xi Za Zhi

December 2024

Department of Respiratory and Critical Care, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha410008, China.

Article Synopsis
  • - Allergic bronchopulmonary aspergillosis (ABPA) is a lung condition that leads to symptoms like wheezing and lung damage, but it often gets misdiagnosed due to its complex symptoms and lack of clear diagnostic guidelines.
  • - Diagnostic criteria for ABPA have evolved over time, starting with the Rosenberg criteria in 1977, followed by improvements from ISHAM in 2013 and 2024, and new criteria for allergic bronchopulmonary mycosis (ABPM) introduced by Asano in 2021, which were found to be more sensitive.
  • - Understanding and applying these updated diagnostic guidelines is important for better diagnosing and treating ABPA and ABPM, as misdiagnosis can lead
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!